Recent cadmium exposure among male partners may affect oocyte fertilization during in vitro fertilization (IVF).

PURPOSE: We recently reported evidence suggesting associations between urine cadmium concentrations, reflecting long-term exposure, measured in 25 female patients (relative risk = 1.41, P = 0.412) and 15 of their male partners (relative risk = 0.19, P = 0.097) and oocyte fertilization in vitro. Blood cadmium concentrations reflect more recent exposure.
METHODS: We here incorporate those measures into our prior data set and employ multivariable log-binomial regression models to generate hypotheses concerning the relative effects of long-term and recent cadmium exposure on oocyte fertilization in vitro.
RESULTS: No association is indicated for blood cadmium from women and oocyte fertilization, adjusted for urine cadmium and creatinine, blood lead and mercury, age, race/ethnicity and cigarette smoking (relative risk = 0.88, P = 0.828). However, we suggest an inverse adjusted association between blood cadmium from men and oocyte fertilization (relative risk = 0.66, P = 0.143).
CONCLUSIONS: These results suggest that consideration of long-term and recent exposures are both important for assessing the effect of partner cadmium levels on oocyte fertilization in vitro.

Introduction

We recently reported data suggesting associations between long-term cadmium (Cd) exposure and oocyte fertilization during in-vitro fertilization (IVF) treatment [1]. These results indicated the possibility of a positive association between concentrations of urine Cd and oocyte fertilization in female IVF patients (adjusted relative risk (aRR) = 1.41). These prior results also suggest the possibility of an inverse association between urine Cd in male partners of IVF patients and oocyte fertilization (aRR = 0.19).

Urine Cd is generally recognized as a marker of long-term exposure, reflecting deposition in the kidney over time, and likely resulting from dietary sources in our study population. In this study, we expand our previous data set to incorporate blood Cd concentrations which reflect recent exposure, on the order of days to weeks [2]. Following exposure, a small proportion of Cd concentrates in the blood, primarily bound to erythrocytes, as well as to plasma albumin and metallothionein and reflects exposure during the preceding 2–3 months [3]. The aim of this preliminary study is to generate hypotheses concerning the relative contribution, if any, of recent Cd exposure to the effects suggested for long-term Cd exposure in our prior study.

Methods

Fifty-eight female patients and 36 male partners undergoing IVF treatment at the UCSF Center for Reproductive Health were recruited to the Study of Metals and Assisted Reproductive Technologies (SMART) between September 1st, 2007 and August 31st, 2008. Sample selection and clinical protocols were previously described in detail [1]. Female patients underwent gonadotropin-induced ovarian stimulation per clinic protocols. When at least two follicles exceeded 17 mm in diameter, human chorionic gonadotropin was administered and oocytes were retrieved 36 h later. Between two and 39 mature oocytes were collected from each woman. Collected oocytes were fertilized by conventional insemination or by intracytoplasmic sperm injection using sperm from male partners or a donor. Approximately 16–18 h following insemination, zygotes were identified by the appearance of two pronuclei. A single whole blood and a single urine specimen were obtained concurrently from each female patient at the time of oocyte retrieval, and from each male partner, when available, on the same day. Blood specimens were obtained from 50 female patients and 33 male partners. Informed consent was obtained from all study participants and the study protocol was approved by the Institutional Review Board of the University of California at San Francisco.

Blood and urine specimens were analyzed for Cd using methods validated for a Perkin Elmer Sciex ELAN DRC II inductively coupled plasma-mass spectrometer (PerkinElmer Life and Analytical Sciences, Shelton, CT) with dynamic reaction cell (DRC-ICP-MS) technology. For each study participant, 1.8 mL cryovials, containing whole blood or urine, were shipped on dry ice to the Wadsworth Center’s Laboratory of Inorganic and Nuclear Chemistry at the New York State (NYS) Department of Health (Albany, NY) for analysis. The Wadsworth Center is certified under NYS, CLIA and OSHA regulations and successfully participates in proficiency testing (PT) programs for blood and urine Cd operated by the NYS Department of Health, the Institut National de Santé Publique du Québec, Le Centre de Toxicologie du Québec, the University of Surrey, UK, as well as in the German External Quality Assessment Scheme, operated by the Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine of the Friedrich-Alexander University, Erlangen-Nuremberg, Germany.

The analytic procedure has been previously described in detail [4] as have the details for the urine Cd, blood hg and blood Pb analyses [1]. The analyses were carried out under Class 100 Clean Room conditions. A minimum of six Cd standards traceable to the National Institute of Standards and Technology (NIST) were used for calibration. Blood and urine specimens were analyzed for Cd by monitoring m/z = 114. Four blood or urine levels of internal quality control (QC) materials were analyzed during each run. Typical coefficients of variation for these assays range from 3% to 6% for blood Cd and 1% to 3% for urine Cd. Method accuracy is periodically assessed by analyzing NIST Standard Reference Material 966 (Toxic Metals in Bovine Blood), and NIST SRM 2670a (Toxic Elements in Urine). Method performance for blood and urine Cd is also assessed via participation in the four external quality assessment schemes previously mentioned. The limit of detection (LOD), defined as three times the standard deviation of concentrations measured in matrix blanks for 10 independent analyses, is 0.2 μg/L for blood and 0.02 μg/L for urine. Values were reported for research purposes without regard for the LOD to preclude the introduction of bias into statistical models [5].

Statistical significance was defined as P < 0.10 for a two-tailed test consistent with the hypothesis generation nature of this study. Non-parametric tests were employed to assess bivariate associations due to lack of normality. Multiple log-binomial regression was used to assess associations between oocyte fertilization (no/yes) and the concentrations of blood and urine Cd with adjustment for urine creatinine, blood Hg, blood Pb, age, race/ethnicity and cigarette smoking. These covariates were selected a priori for inclusion in multiple log-binomial regression models using literature review followed by incorporation into directed acyclic graphs (DAGs). Directed acyclic graphs employ causal graphing theory to identify a minimally sufficient set of variables with which to control confounding under a postulated causal pathway [6]. Clinical variables, including semen quality, ICSI vs. conventional insemination, and other treatment related factors represent intermediate variables in the causal pathway between exposure (i.e., metals concentrations) and endpoint (i.e., oocyte fertilizations). Thus, these variables were excluded from multivariable analysis to preclude the introduction of bias that would result from their incorporation [7]. Generalized estimating equations (GEE) were used to generate robust standard errors. The Quasi-likelihood information criterion (QIC) was used to assess model fit given the non-likelihood based nature of GEE; a smaller QIC value indicates improved model fit [8]. SAS v.9.2 (SAS Institute, Cary, NC) was used for all statistical analyses.

Results

Table 1 shows the distribution of blood Cd concentrations measured on the day of oocyte collection in female patients and their male partners; 68% and 42.4% of female and male values were above the LOD respectively. Concentrations of blood and urine Cd are correlated in female patients (r = 0.47, P = 0.0008) but not in male partners (r = 0.17, P = 0.350). A larger proportion of each woman’s oocytes were fertilized by ICSI (median = 0.76, n = 37) than by conventional insemination (median = 0.56, n = 21). However, no significant difference is detected by insemination protocol for concentrations of metals measured in women (P > 0.219) or men (P > 0.235).

Table 1

Distribution of blood and urine cadmium concentrations measured on the day of oocyte collection in female patients and their male partners; the Study of Metals and Assisted Reproductive Technologies (SMART)

	n	Mean	SD	Min	Median	Max	r a
Female patients
Blood cadmium (μg/L)	50	0.40	0.51	0.08	0.27	3.60	0.47 **
Urine cadmium (μg/g creatinine)	55	0.30	0.17	0.04	0.30	0.98
Male partners
Blood cadmium (μg/L)	33	0.23	0.19	0.05	0.18	0.97	0.17
Urine cadmium (μg/g creatinine)	36	0.15	0.11	−0.07	0.13	0.51

aCorrelation coefficients for blood cadmium and urine cadmium

Max, maximum value; Min, minimum value; SD, standard deviation ** P ≤ 0.10

The log-binomial regression of oocyte fertilization on urine and blood Cd measured in 25 female patients is presented in Table 2. As reported previously, Model 1 for female patients including urine Cd as the sole predictor of interest suggests a 41% increase in the probability for oocyte fertilization per µg/L increase in urine Cd. In Model 2, the addition of blood Cd concentrations to Model 1 has little impact on the effect of urine Cd (i.e., a 5% increase in magnitude) and does not improve model fit as indicated by the increase in QIC value (i.e., 452.91–444.50 = +8.41). Asian race/ethnicity among female patients is a positive predictor of oocyte fertilization in Model 2 in which blood and urine Cd are the predictors of interest (RR = 1.27, P = 0.0316), consistent with our prior report [1].

Table 2

Multiple log-binomial regression models of oocyte fertilization in vitro on concentrations of urine and/or blood cadmium measured in 25 female patients and 15 male partners, with generalized estimating equations used to generate robust standard errors; the Study of Metals and Assisted Reproductive Technologies (SMART)

	Models a	Variables	RR	95% CI		p-value	QIC
				Low	High
Female patients	Model 1	Urine cadmium (μg/L)	1.41	0.62	3.17	0.412	444.50
	Model 2	Urine cadmium (μg/L)	1.48	0.60	3.66	0.391	452.91
		Blood cadmium (μg/L)	0.88	0.28	2.80	0.828
Male partners	Model 1	Urine cadmium (μg/L)	0.19	0.03	1.35	0.097	309.53
	Model 2	Urine cadmium (μg/L)	0.14	0.02	1.32	0.087	307.00
		Blood cadmium (μg/L)	0.66	0.38	1.15	0.143

CI confidence interval, RR Relative risk for oocyte fertilization, QIC Quasi-likelihood Information Criteria

aModels include blood lead, blood mercury, age, race/ethnicity, cigarette smoking and urine creatinine (mg/dL) entered as covariates

The adjusted log-binomial regression models of oocyte fertilization on urine and blood Cd measured in 15 male partners is also presented in Table 2. As reported previously, Model 1, including urine Cd as the only predictor of interest, suggests an 81% decrease in the probability for oocyte fertilization per µg/L increase in urine Cd concentration. In Model 2, the addition of blood Cd concentrations to Model 1 has a substantial impact on the effect of urine Cd (i.e., 26% increase in magnitude) and model fit is improved (i.e., 307.00–309.53 = −2.53). Furthermore, Model 2 suggests that a µg/L increase in blood Cd concentrations is associated with a 34% decrease in the probability for oocyte fertilization, conditional on urine Cd concentrations and other covariates. Cigarette smoking among male partners is a positive predictor of oocyte fertilization in Model 2 in which blood and urine Cd are the predictors of interest (RR = 1.95, P < 0.0001), consistent with our prior report [1]. In contrast to this observation, unadjusted analysis demonstrates no association between smoking and oocyte fertilization (RR = 1.04, P = 0.754) indicating that this association is confounded by the considered covariates.

Discussion

In this study we expand our prior data set [1] by incorporating blood Cd concentrations and present evidence suggesting the potential importance of recent male Cd exposure on oocyte fertilization in vitro. The results of this preliminary study raise the possibility of a gender specific effect in which blood Cd concentrations in male IVF partners, but not female patients, appear to be important.

The blood Cd concentrations measured in our samples are similar to or less than those measured for the U.S. population as reported by the National Health and Nutrition Examination Survey [9]. Median (95% CI) blood Cd concentrations for female patients and male partners are 0.27 µg/L (0.22–0.37) and 0.18 µg/L (0.14–0.21), respectively. Median (95% CI) blood Cd concentrations for U.S. females and males are 0.30 µg/L (<0.30 (LOD)−0.30) and 0.30 µg/L (0.30–0.40) respectively. We previously reported a similar pattern for urine Cd concentrations in which the median value for female IVF patients is similar to that reported for U.S. females, and the median value for the male partners is somewhat lower than that reported for U.S. males [1].

Here we report a positive correlation between urine and blood Cd concentrations in female patients (r = 0.47, P = 0.0008). This result is consistent with that from the log-binomial regression model (i.e., “Model 2”), indicating that blood Cd and urine Cd may be markers for the same exposure, vis a vis, blood Cd does not contribute different information than does urine Cd. Other investigators have previously reported similar findings (r = 0.39, P < 0.01) for the correlation between blood and urine Cd in women [10]. A recent study of women undergoing IVF reported no association between blood Cd and oocyte fertilization [11], consistent with the results of this study.

In contrast to the results for female patients, blood and urine Cd in males partners were not correlated (r = 0.17, P = 0.350). This result underscores the improvement detected for the fit of the log-binomial model for oocyte fertilization, upon the inclusion of blood Cd as an additional predictor variable (i.e., change in QIC = −2.53). Numerous studies indicate inverse associations between blood Cd concentrations and sperm quality, including count, morphology, and motility [12, 13]. In contrast, data describing associations between blood Cd levels and oocyte fertilization is comparatively sparse. Additional studies describe inverse association between seminal Cd concentrations and human fertility [14, 15] although we did not have these measures available.

It is tempting to speculate with regard to biologic mechanisms that might be involved in the suggested positive or inverse associations between oocyte fertilization and Cd exposure in female IVF patients and Cd exposure in male IVF partners, respectively. Several toxic metals, including Cd2+, enter eukaryotic cells directly [16] via Ca2+ channels and may directly bind to and interfere with cytoskeletal function [17] and/or the estrogen receptor [18]. Cadmium accumulating in reproductive tissues might directly enter cells of the cumulus-oocyte-complex [19, 20] or be delivered to the oocyte while bound to penetrating sperm [14, 21]. Once within a cell Cd2+ might elicit oxidative damage directly [22], leading to mitotic failure or cell death, or indirectly by depleting intracellular stores of thiols and thereby limiting anti-oxidant enzyme activity [23]. Furthermore, Cd2+ may bind the intracellular estrogen receptor [18, 24] in agonistic fashion and might thereby alter the complex gonadotropin-mediated process of fertilization induced meiotic resumption [25].

A penetrating sperm not only delivers the paternal haploid genome to an oocyte but also a heretofore unknown meiosis resumption signal and a centriole which is required for microtubule assembly and initial zygote development [26]. Metals bound to the cytoskeletal elements of spermatozoa, such as Cd, might interfere with resumption of oocyte meiosis and consequently oocyte fertilization in ICSI and conventional insemination cases [27]. Alternately, Cd-induced toxicity of sperm may directly account for the inverse association suggested for male urine Cd and oocyte fertilization in this study [14]. Unfortunately, we did not have sperm quality/function data available for this preliminary study and thus evaluation of this possibility will also require further study. The conditionally-independent effects suggested for recent and long-term Cd exposure among males may reflect different biologic mechanisms associated with the distinct exposure patterns, such as oxidative stress and estrogen receptor binding, respectively.

To our knowledge, this preliminary study constitutes the first report of a possible association between oocyte fertilization in vitro and recent Cd exposure among males, conditionally independent of the effects of long-term exposure. Due to the limited sample size we were unable to simultaneously evaluate exposures in women and men, or to explore potential effect modification by insemination protocol, a scenario in which associations between metals and oocyte fertilization may differ in ICSI vs. conventional insemination couples. As an intermediate variable in the causal pathway between exposure and endpoint, insemination protocol does not confound associations between metals and oocyte fertilization; however, differences in the proportions of fertilized oocytes by these approaches raise the possibility for effect modification. Furthermore, a substantial proportion of values were below the LOD which somewhat undermines these study results. The results of this study can only be considered preliminary; however, they indicate that both recent and long-term Cd exposure should be considered when assessing the impact of exposure on oocyte fertilization during IVF.

Conclusion

A future study, with a larger sample size will permit not only increased statistical power but will facilitate simultaneous consideration of female and male exposures [28], both long-term and recent, and oocyte fertilization during IVF, and permit consideration of effect modification by insemination protocol.